Department of Internal Medicine, Cantonal Hospital Muensterlingen, Muensterlingen, Switzerland.
Department of Internal Medicine, Cantonal Hospital Muensterlingen, Muensterlingen, Switzerlandh.
Swiss Med Wkly. 2024 Mar 27;154:3708. doi: 10.57187/s.3708.
Knowing whether shift work negatively affects the immune system's response to COVID-19 vaccinations could be valuable for planning future vaccination campaigns for healthcare workers. We aimed to determine the impact of working late or night shifts on serum anti-SARS-CoV-2 spike protein immunoglobulin G (anti-S) antibody levels after primary SARS-CoV-2-mRNA vaccination.
To obtain detailed information on shift work, we sent a separate online questionnaire to 1475 eligible healthcare workers who participated in a prospective longitudinal study conducted in 15 healthcare institutions in Switzerland. We asked all vaccinated healthcare workers with available anti-S antibody levels after vaccination to complete a brief online survey on their working schedules within one week before and after primary mRNA vaccination. We used multivariate regression to evaluate the association between work shifts around primary vaccination and anti-S antibody levels. We adjusted for confounders already known to influence vaccine efficacy (e.g. age, sex, immunosuppression, and obesity) and for variables significant at the 0.05 alpha level in the univariate analyses.
The survey response rate was 43% (n = 638). Ninety-eight responders were excluded due to unknown vaccination dates, different vaccines, or administration of the second dose shortly (within 14 days) after or before serologic follow-up. Of the 540 healthcare workers included in our analysis, 175 (32.4%) had worked at least one late or night shift within seven days before and/or after primary vaccination. In the univariate analyses, working late or night shifts was associated with a nonsignificant -15.1% decrease in serum anti-S antibody levels (p = 0.090). In the multivariate analysis, prior infection (197.2% increase; p <0.001) and immunisation with the mRNA-1273 vaccine (63.7% increase compared to the BNT162b2 vaccine; p <0.001) were the strongest independent factors associated with increased anti-S antibody levels. However, the impact of shift work remained statistically nonsignificant (-13.5%, p = 0.108).
Working late or night shifts shortly before or after mRNA vaccination against COVID-19 does not appear to significantly impact serum anti-S antibody levels. This result merits consideration since it supports flexible vaccination appointments for healthcare workers, including those working late or night shifts.
了解轮班工作是否会对 COVID-19 疫苗接种后的免疫系统反应产生负面影响,对于规划未来医护人员的疫苗接种活动可能具有重要意义。我们旨在确定轮班工作(上晚班或夜班)对初次接种 SARS-CoV-2 mRNA 疫苗后血清抗 SARS-CoV-2 刺突蛋白免疫球蛋白 G(抗-S)抗体水平的影响。
为了详细了解轮班工作情况,我们向参与瑞士 15 家医疗机构进行的前瞻性纵向研究的 1475 名合格医护人员发送了一份单独的在线问卷。我们要求所有接种疫苗且接种后有可用抗-S 抗体水平的医护人员在初次 mRNA 疫苗接种前和后一周内完成一份关于其工作时间表的简短在线调查。我们使用多变量回归来评估初次接种前后的轮班工作与抗-S 抗体水平之间的关联。我们调整了已知会影响疫苗效力的混杂因素(例如年龄、性别、免疫抑制和肥胖)以及单变量分析中显著性水平为 0.05 的变量。
调查回复率为 43%(n=638)。由于未知的接种日期、不同的疫苗或第二次接种剂量在血清学随访后 14 天内(或之前)不久进行,98 名应答者被排除在外。在我们的分析中,共有 540 名医护人员,其中 175 名(32.4%)在初次接种前后 7 天内至少上了一次晚班或夜班。在单变量分析中,上晚班或夜班与血清抗-S 抗体水平的非显著降低 15.1%相关(p=0.090)。在多变量分析中,既往感染(增加 197.2%;p<0.001)和接种 mRNA-1273 疫苗(与 BNT162b2 疫苗相比,增加 63.7%;p<0.001)是与抗-S 抗体水平升高相关的最强独立因素。然而,轮班工作的影响仍然具有统计学意义(-13.5%,p=0.108)。
在接种 COVID-19 mRNA 疫苗前后上晚班或夜班似乎不会显著影响血清抗-S 抗体水平。由于支持为包括上晚班或夜班的医护人员灵活安排疫苗接种,因此该结果值得考虑。